{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:07:01Z","timestamp":1782176821187,"version":"3.54.5"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-023-10009-3","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T06:02:06Z","timestamp":1691042526000},"page":"673-685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Diagnostic performance of whole-body [18F]FDG PET\/MR in cancer M staging: A systematic review and meta-analysis"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2271-9764","authenticated-orcid":false,"given":"Seyed Ali","family":"Mirshahvalad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Kohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ur","family":"Metser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricarda","family":"Hinzpeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Farag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Veit-Haibach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"key":"10009_CR1","doi-asserted-by":"publisher","first-page":"928","DOI":"10.2967\/jnumed.112.105338","volume":"53","author":"C Buchbender","year":"2012","unstructured":"Buchbender C, Heusner TA, Lauenstein TC, Bockisch A, Antoch G (2012) Oncologic PET\/MRI, part 1: Tumors of the brain, head and neck, chest, abdomen, and pelvis. J Nucl Med 53:928\u2013938","journal-title":"J Nucl Med"},{"key":"10009_CR2","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/sj.bjc.6605214","volume":"101","author":"LL Chen","year":"2009","unstructured":"Chen LL, Blumm N, Christakis NA, Barabasi AL, Deisboeck TS (2009) Cancer metastasis networks and the prediction of progression patterns. Br J Cancer 101:749\u2013758","journal-title":"Br J Cancer"},{"key":"10009_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y (2020) Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther 5:1\u201317","journal-title":"Signal Transduct Target Ther"},{"key":"10009_CR4","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2967\/jnumed.107.047787","volume":"49","author":"JW Fletcher","year":"2008","unstructured":"Fletcher JW, Djulbegovic B, Soares HP et al (2008) Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 49:480\u2013508","journal-title":"J Nucl Med"},{"key":"10009_CR5","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.2967\/jnumed.108.054098","volume":"50","author":"H Jadvar","year":"2009","unstructured":"Jadvar H, Alavi A, Gambhir SS (2009) 18F-FDG uptake in lung, breast, and colon cancers: Molecular biology correlates and disease characterization. J Nucl Med 50:1820\u20131827","journal-title":"J Nucl Med"},{"key":"10009_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40644-015-0053-1","volume":"15","author":"K Miles","year":"2015","unstructured":"Miles K, McQueen L, Ngai S, Law P (2015) Evidence-based medicine and clinical fluorodeoxyglucose PET\/MRI in oncology. Cancer Imaging 15:1\u20138","journal-title":"Cancer Imaging"},{"key":"10009_CR7","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1007\/s00259-019-04402-8","volume":"46","author":"A Morsing","year":"2019","unstructured":"Morsing A, Hildebrandt MG, Vilstrup MH (2019) Hybrid PET\/MRI in major cancers: a scoping review. Eur J Nucl Med Mol Imaging 46:2138\u20132151","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10009_CR8","doi-asserted-by":"publisher","unstructured":"Weber W (2020) Clinical PET\/MR. In: Schober O, Kiessling F, Debus J (eds) Molecular Imaging in Oncology. Recent Results in Cancer Research, vol 216. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-030-42618-7_22","DOI":"10.1007\/978-3-030-42618-7_22"},{"key":"10009_CR9","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s12149-017-1164-5","volume":"31","author":"A Singnurkar","year":"2017","unstructured":"Singnurkar A, Poon R, Metser U (2017) Comparison of 18F-FDG-PET\/CT and 18F-FDG-PET\/MR imaging in oncology: a systematic review. Ann Nucl Med 31:366\u2013378","journal-title":"Ann Nucl Med"},{"key":"10009_CR10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1053\/j.semnuclmed.2021.11.012","volume":"52","author":"R Seifert","year":"2022","unstructured":"Seifert R, Kersting D, Rischpler C et al (2022) Clinical Use of PET\/MR in Oncology: An Update. Semin Nucl Med 52:356\u2013364","journal-title":"Semin Nucl Med"},{"key":"10009_CR11","doi-asserted-by":"publisher","unstructured":"Salameh J, Bossuyt PM, McGrath TA, et al. (2020) Preferred reporting items for systematic review and metaanalysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist. BMJ 370:m2632.\u00a0https:\/\/doi.org\/10.1136\/bmj.m2632","DOI":"10.1136\/bmj.m2632"},{"key":"10009_CR12","doi-asserted-by":"publisher","unstructured":"Deeks JJ, Higgins JP, Altman DG (2008) Analysing Data and Undertaking Meta-Analyses. In Cochrane Handbook for Systematic Reviews of Interventions (eds J.P. Higgins and S. Green). https:\/\/doi.org\/10.1002\/9780470712184.ch9","DOI":"10.1002\/9780470712184.ch9"},{"key":"10009_CR13","unstructured":"Dwamena B (2009) MIDAS: Stata module for meta-analytical integration of diagnostic test accuracy studies. https:\/\/EconPapers.repec.org\/RePEc:boc:bocode:s456880"},{"key":"10009_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/1536867X0900900203","volume":"9","author":"RM Harbord","year":"2009","unstructured":"Harbord RM, Whiting P (2009) Metandi: meta-analysis of diagnostic accuracy using hierarchical logistic regression. Stata J 9:211\u2013229","journal-title":"Stata J"},{"key":"10009_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00259-014-2902-8","volume":"42","author":"K Beiderwellen","year":"2015","unstructured":"Beiderwellen K, Grueneisen J, Ruhlmann V et al (2015) [18F]FDG PET\/MRI vs. PET\/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results. Eur J Nucl Med Mol Imaging 42:56\u201365","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10009_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s11307-019-01413-7","volume":"22","author":"D Berzaczy","year":"2020","unstructured":"Berzaczy D, Fueger B, Hoeller C et al (2020) Whole-Body [18F]FDG-PET\/MRI vs. [18F]FDG-PET\/CT in Malignant Melanoma. Mol Imaging Biol 22:739\u2013744","journal-title":"Mol Imaging Biol"},{"key":"10009_CR17","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.7081","volume":"7","author":"LH Bian","year":"2019","unstructured":"Bian LH, Wang M, Gong J et al (2019) Comparison of integrated PET\/MRI with PET\/CT in evaluation of endometrial cancer: a retrospective analysis of 81 cases. PeerJ 7:e7081","journal-title":"PeerJ"},{"key":"10009_CR18","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s00330-018-5720-8","volume":"29","author":"D Botsikas","year":"2019","unstructured":"Botsikas D, Bagetakos I, Picarra M et al (2019) What is the diagnostic performance of 18-FDG-PET\/MR compared to PET\/CT for the N- and M- staging of breast cancer? Eur Radiol 29:1787\u20131798","journal-title":"Eur Radiol"},{"key":"10009_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00259-015-3137-z","volume":"43","author":"C Brendle","year":"2016","unstructured":"Brendle C, Schwenzer NF, Rempp H et al (2016) Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET\/MRI and PET\/CT in a short case series. Eur J Nucl Med Mol Imaging 43:123\u2013132","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10009_CR20","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1007\/s00259-020-04801-2","volume":"47","author":"NM Bruckmann","year":"2020","unstructured":"Bruckmann NM, Sawicki LM, Kirchner J et al (2020) Prospective evaluation of whole-body MRI and 18F-FDG PET\/MRI in N and M staging of primary breast cancer patients. Eur J Nucl Med Mol Imaging 47:2816\u20132825","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10009_CR21","doi-asserted-by":"publisher","unstructured":"Bruckmann NM, Kirchner J, Morawitz J, et al. (2021) Prospective comparison of CT and 18F-FDG PET\/MRI in N and M staging of primary breast cancer patients: Initial results. PLoS One 16: e0260804. https:\/\/doi.org\/10.1371\/journal.pone.0260804","DOI":"10.1371\/journal.pone.0260804"},{"key":"10009_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3892\/ijo.2017.4012","volume":"51","author":"OA Catalano","year":"2017","unstructured":"Catalano OA, Daye D, Signore A et al (2017) Staging performance of whole-body DWI, PET\/CT and PET\/MRI in invasive ductal carcinoma of the breast. Int J Oncol 51:281\u2013288","journal-title":"Int J Oncol"},{"key":"10009_CR23","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00261-016-0985-3","volume":"42","author":"OA Catalano","year":"2017","unstructured":"Catalano OA, Coutinho AM, Sahani DV (2017) Colorectal cancer staging: comparison of whole-body PET\/CT and PET\/MR. Abdom Radiol (NY) 42:1141\u20131151","journal-title":"Abdom Radiol (NY)"},{"key":"10009_CR24","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s00259-019-04558-3","volume":"47","author":"C Ferrone","year":"2020","unstructured":"Ferrone C, Goyal L, Qadan M et al (2020) Management implications of fluorodeoxyglucose positron emission tomography\/magnetic resonance in untreated intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging 47:1871\u20131884","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10009_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00259-014-2873-9","volume":"42","author":"F Fraioli","year":"2015","unstructured":"Fraioli F, Screaton NJ, Janes SM et al (2015) Non-small-cell lung cancer resectability: diagnostic value of PET\/MR. Eur J Nucl Med Mol Imaging 42:49\u201355","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10009_CR26","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/RLI.0000000000000086","volume":"49","author":"J Grueneisen","year":"2014","unstructured":"Grueneisen J, Beiderwellen K, Heusch P et al (2014) Simultaneous Positron Emission Tomography\/Magnetic Resonance Imaging for Whole-Body Staging in Patients With Recurrent Gynecological Malignancies of the Pelvis A Comparison to Whole-Body Magnetic Resonance Imaging Alone. Invest Radiol 49:808\u2013815","journal-title":"Invest Radiol"},{"key":"10009_CR27","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.2967\/jnumed.114.146886","volume":"55","author":"J Grueneisen","year":"2014","unstructured":"Grueneisen J, Schaarschmidt BM, Beiderwellen K et al (2014) Diagnostic value of diffusion-weighted imaging in simultaneous 18F-FDG PET\/MR imaging for whole-body staging of women with pelvic malignancies. J Nucl Med 55:1930\u20131935","journal-title":"J Nucl Med"},{"key":"10009_CR28","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1007\/s00259-015-3131-5","volume":"42","author":"J Grueneisen","year":"2015","unstructured":"Grueneisen J, Schaarschmidt BM, Heubner M et al (2015) Integrated PET\/MRI for whole-body staging of patients with primary cervical cancer: preliminary results. Eur J Nucl Med Mol Imaging 42:1814\u20131824","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10009_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00259-014-2885-5","volume":"42","author":"P Heusch","year":"2015","unstructured":"Heusch P, Nensa F, Schaarschmidt B et al (2015) Diagnostic accuracy of whole-body PET\/MRI and whole-body PET\/CT for TNM staging in oncology. Eur J Nucl Med Mol Imaging 42:42\u201348","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10009_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2967\/jnumed.115.162040","volume":"57","author":"MW Huellner","year":"2016","unstructured":"Huellner MW, de Galiza BF, Husmann L et al (2016) TNM Staging of Non-Small Cell Lung Cancer: Comparison of PET\/MR and PET\/CT. J Nucl Med 57:21\u201326","journal-title":"J Nucl Med"},{"key":"10009_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1148\/radiol.2016152798","volume":"282","author":"I Joo","year":"2017","unstructured":"Joo I, Lee JM, Lee DH et al (2017) Preoperative assessment of pancreatic cancer with FDG PET\/MR imaging versus FDG PET\/CT plus contrast-enhanced multidetector CT: A prospective preliminary study. Radiology 282:149\u2013159","journal-title":"Radiology"},{"key":"10009_CR32","doi-asserted-by":"publisher","unstructured":"Kirchner J, Sawicki LM, Deuschl C, et al (2017) 18 F-FDG PET\/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine. PLoS One 12:e0180349. https:\/\/doi.org\/10.1371\/journal.pone.0180349","DOI":"10.1371\/journal.pone.0180349"},{"key":"10009_CR33","doi-asserted-by":"publisher","unstructured":"Kirchner J, Martin O, Umutlu L, et al (2020) Impact of 18F-FDG PET\/MR on therapeutic management in high risk primary breast cancer patients \u2013 A prospective evaluation of staging algorithms. Eur J Radiol 128:108975. https:\/\/doi.org\/10.1016\/j.ejrad.2020.108975","DOI":"10.1016\/j.ejrad.2020.108975"},{"key":"10009_CR34","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1007\/s00259-020-04938-0","volume":"47","author":"M Klain","year":"2020","unstructured":"Klain M, Nappi C, Nicolai E et al (2020) Comparison of simultaneous 18F-2-[18F] FDG PET\/MR and PET\/CT in the follow-up of patients with differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 47:3066\u20133073","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10009_CR35","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.1097\/RLU.0000000000000812","volume":"40","author":"SJ Lee","year":"2015","unstructured":"Lee SJ, Seo HJ, Kang KW et al (2015) Clinical performance of whole-body 18F-FDG PET\/Dixon-VIBE, T1-weighted, and T2-weighted MRI protocol in colorectal cancer. Clin Nucl Med 40:e392\u2013e398","journal-title":"Clin Nucl Med"},{"key":"10009_CR36","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.ejrad.2016.03.015","volume":"85","author":"DH Lee","year":"2016","unstructured":"Lee DH, Kim SH, Joo I, Hur BY, Han JK (2016) Comparison between 18F-FDG PET\/MRI and MDCT for the assessment of preoperative staging and resectability of gastric cancer. Eur J Radiol 85:1085\u20131091","journal-title":"Eur J Radiol"},{"key":"10009_CR37","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1007\/s00330-016-4255-0","volume":"26","author":"SM Lee","year":"2016","unstructured":"Lee SM, Goo JM, Park CM et al (2016) Preoperative staging of non-small cell lung cancer: prospective comparison of PET\/MR and PET\/CT. Eur Radiol 26:3850\u20133857","journal-title":"Eur Radiol"},{"key":"10009_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9103163","volume":"9","author":"CC Li","year":"2020","unstructured":"Li CC, Chien TM, Huang SP et al (2020) 18 f-fdg pet\/mr versus mr alone in whole-body primary staging and restaging of patients with rectal cancer: What is the benefit of pet? J Clin Med 9:1\u201311","journal-title":"J Clin Med"},{"key":"10009_CR39","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.2147\/CMAR.S293005","volume":"13","author":"H Li","year":"2021","unstructured":"Li H, Chen X, Zhang Y, Wang K, Gao Z (2021) Value of18f-fdg hybrid pet\/mr in differentiated thyroid cancer patients with negative131i whole-body scan and elevated thyroglobulin levels. Cancer Manag Res 13:2869\u20132876","journal-title":"Cancer Manag Res"},{"key":"10009_CR40","doi-asserted-by":"publisher","unstructured":"Yi Liu, Dong Zheng, Jia-jin Liu, et al. (2019) Comparing PET\/MRI with PET\/CT for pretreatment staging of gastric cancer. Gastroenterol Res Pract 9564627.\u00a0https:\/\/doi.org\/10.1155\/2019\/9564627","DOI":"10.1155\/2019\/9564627"},{"key":"10009_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1148\/radiol.2016151155","volume":"281","author":"AN Melsaether","year":"2016","unstructured":"Melsaether AN, Raad RA, Pujara AC et al (2016) Comparison of Whole-Body F-18 FDG PET\/MR Imaging and Whole-Body F-18 FDG PET\/CT in Terms of Lesion Detection and Radiation Dose in Patients with Breast Cancer. Radiology 281:193\u2013202","journal-title":"Radiology"},{"key":"10009_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13550-017-0352-6","volume":"8","author":"JE Mongula","year":"2018","unstructured":"Mongula JE, Bakers FC, V\u00f6\u00f6 S et al (2018) Positron emission tomography-magnetic resonance imaging (PET-MRI) for response assessment after radiation therapy of cervical carcinoma: a pilot study. EJNMMI Res 8:1\u20138","journal-title":"EJNMMI Res"},{"key":"10009_CR43","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1148\/radiol.14140936","volume":"275","author":"Y Ohno","year":"2015","unstructured":"Ohno Y, Koyama H, Yoshikawa T et al (2015) Three-way comparison of whole-body MR, coregistered whole-body FDG PET\/MR, and integrated whole-body FDG PET\/CT imaging: TNM and stage assessment capability for non-small cell lung cancer patients. Radiology 275:849\u2013861","journal-title":"Radiology"},{"key":"10009_CR44","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/jmri.25726","volume":"46","author":"Y Ohno","year":"2017","unstructured":"Ohno Y, Yoshikawa T, Kishida Y et al (2017) Diagnostic performance of different imaging modalities in the assessment of distant metastasis and local recurrence of tumor in patients with non-small cell lung cancer. J Magn Reson Imaging 46:1707\u20131717","journal-title":"J Magn Reson Imaging"},{"key":"10009_CR45","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2214\/AJR.18.20111","volume":"212","author":"Y Ohno","year":"2019","unstructured":"Ohno Y, Yui M, Aoyagi K et al (2019) Whole-Body MRI: Comparison of its capability for TNM staging of malignant pleural mesothelioma with that of coregistered PET\/MRI, Integrated FDG PET\/CT, and conventional imaging. AJR Am J Roentgenol 212:311\u2013319","journal-title":"AJR Am J Roentgenol"},{"key":"10009_CR46","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.2214\/AJR.19.22565","volume":"215","author":"Y Ohno","year":"2020","unstructured":"Ohno Y, Takeshi Y, Takenaka D, Koyama H, Aoyagi K, Yui M (2020) Comparison of Diagnostic Accuracy for TNM Stage Among Whole-Body MRI and Coregistered PET\/MRI Using 1.5-T and 3-T MRI Systems and Integrated PET\/CT for Non-Small Cell Lung Cancer. AJR Am J Roentgenol 215:1191\u20131198","journal-title":"AJR Am J Roentgenol"},{"key":"10009_CR47","doi-asserted-by":"publisher","first-page":"899","DOI":"10.2214\/AJR.21.26868","volume":"218","author":"Y Ohno","year":"2022","unstructured":"Ohno Y, Yoshikawa T, Takenaka D et al (2022) Small Cell Lung Cancer Staging: Prospective Comparison of Conventional Staging Tests, FDG PET\/CT, Whole-Body MRI, and Coregistered FDG PET\/MRI. AJR Am J Roentgenol 218:899\u2013908","journal-title":"AJR Am J Roentgenol"},{"key":"10009_CR48","doi-asserted-by":"publisher","unstructured":"Piao Y, Cao C, Xu Y et al (2022) Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET\/MR. Eur Arch Otorhinolaryngol 279:353\u2013359. https:\/\/doi.org\/10.1007\/s00405-021-06779-5","DOI":"10.1007\/s00405-021-06779-5"},{"key":"10009_CR49","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.clinimag.2016.11.016","volume":"42","author":"I Platzek","year":"2017","unstructured":"Platzek I, Beuthien-Baumann B, Schramm G et al (2017) FDG PET\/MR in initial staging of sarcoma: Initial experience and comparison with conventional imaging. Clin Imaging 42:126\u2013132","journal-title":"Clin Imaging"},{"key":"10009_CR50","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/tbj.12569","volume":"22","author":"AC Pujara","year":"2016","unstructured":"Pujara AC, Raad RA, Ponzo F et al (2016) Standardized uptake values from PET\/MRI in metastatic breast cancer: An organ-based comparison with PET\/CT. Breast J 22:264\u2013273","journal-title":"Breast J"},{"key":"10009_CR51","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1007\/s00330-015-3657-8","volume":"25","author":"MA Queiroz","year":"2015","unstructured":"Queiroz MA, Kubik-Huch RA, Hauser N et al (2015) PET\/MRI and PET\/CT in advanced gynaecological tumours: initial experience and comparison. Eur Radiol 25:2222\u20132230","journal-title":"Eur Radiol"},{"key":"10009_CR52","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s00259-020-04911-x","volume":"48","author":"MA Queiroz","year":"2021","unstructured":"Queiroz MA, Ortega CD, Ferreira FR, Nahas SC, Cerri GG, Buchpiguel CA (2021) Diagnostic accuracy of FDG-PET\/MRI versus pelvic MRI and thoracic and abdominal CT for detecting synchronous distant metastases in rectal cancer patients. Eur J Nucl Med Mol Imaging 48:186\u2013195","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10009_CR53","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.ejrad.2016.08.020","volume":"85","author":"V Ruhlmann","year":"2016","unstructured":"Ruhlmann V, Ruhlmann M, Bellendorf A et al (2016) Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET\/MRI versus PET\/CT. Eur J Radiol 85:1941\u20131947","journal-title":"Eur J Radiol"},{"key":"10009_CR54","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00259-017-3809-y","volume":"45","author":"T Sarabhai","year":"2018","unstructured":"Sarabhai T, Schaarschmidt BM, Wetter A et al (2018) Comparison of 18F-FDG PET\/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervix. Eur J Nucl Med Mol Imaging 45:67\u201376","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10009_CR55","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ejrad.2015.12.010","volume":"85","author":"LM Sawicki","year":"2016","unstructured":"Sawicki LM, Grueneisen J, Schaarschmidt BM et al (2016) Evaluation of 18F-FDG PET\/MRI, 18F-FDG PET\/CT, MRI, and CT in whole-body staging of recurrent breast cancer. Eur J Radiol 85:459\u2013465","journal-title":"Eur J Radiol"},{"key":"10009_CR56","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s00259-017-3881-3","volume":"45","author":"LM Sawicki","year":"2018","unstructured":"Sawicki LM, Kirchner J, Grueneisen J et al (2018) Comparison of 18F\u2013FDG PET\/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up study. Eur J Nucl Med Mol Imaging 45:622\u2013629","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10009_CR57","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.clinimag.2017.01.003","volume":"42","author":"T Sekine","year":"2017","unstructured":"Sekine T, de Galiza BF, Kuhn FP et al (2017) PET plus MR versus PET\/CT in the initial staging of head and neck cancer, using a trimodality PET\/CT plus MR system. Clin Imaging 42:232\u2013239","journal-title":"Clin Imaging"},{"key":"10009_CR58","doi-asserted-by":"publisher","first-page":"E88","DOI":"10.1097\/RLU.0000000000001461","volume":"42","author":"T Sekine","year":"2017","unstructured":"Sekine T, de Galiza BF, Sah BR et al (2017) PET\/MR Outperforms PET\/CT in Suspected Occult Tumors. Clin Nucl Med 42:E88\u2013E95","journal-title":"Clin Nucl Med"},{"key":"10009_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41824-021-00117-y","volume":"5","author":"AR Sharkey","year":"2021","unstructured":"Sharkey AR, Sah BR, Withey SJ et al (2021) Initial experience in staging primary oesophageal\/gastro-oesophageal cancer with 18F-FDG PET\/MRI. Eur J Hybrid Imaging 5:1\u20133","journal-title":"Eur J Hybrid Imaging"},{"key":"10009_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40644-020-00372-5","volume":"21","author":"A Steiner","year":"2021","unstructured":"Steiner A, Narva S, Rinta-Kiikka I, Hietanen S, Hynninen J, Virtanen J (2021) Diagnostic efficiency of whole-body 18F-FDG PET\/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer. Cancer Imaging 21:1\u20131","journal-title":"Cancer Imaging"},{"key":"10009_CR61","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.ejrad.2014.09.008","volume":"83","author":"S Taneja","year":"2014","unstructured":"Taneja S, Jena A, Goel R, Sarin R, Kaul S (2014) Simultaneous whole-body 18F-FDG PET-MRI in primary staging of breast cancer: A pilot study. Eur J Radiol 83:2231\u20132239","journal-title":"Eur J Radiol"},{"key":"10009_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13550-020-00712-3","volume":"10","author":"H Tsuyoshi","year":"2020","unstructured":"Tsuyoshi H, Tsujikawa T, Yamada S, Okazawa H, Yoshida Y (2020) Diagnostic value of F-18 FDG PET\/MRI for staging in patients with ovarian cancer. EJNMMI Res 10:1\u20134","journal-title":"EJNMMI Res"},{"key":"10009_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40644-020-00357-4","volume":"20","author":"H Tsuyoshi","year":"2020","unstructured":"Tsuyoshi H, Tsujikawa T, Yamada S, Okazawa H, Yoshida Y (2020) Diagnostic value of 18F-FDG PET\/MRI for staging in patients with endometrial cancer. Cancer Imaging 20:1\u20139","journal-title":"Cancer Imaging"},{"key":"10009_CR64","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/diagnostics11020202","volume":"11","author":"H Tsuyoshi","year":"2021","unstructured":"Tsuyoshi H, Tsujikawa T, Yamada S, Okazawa H, Yoshida Y (2021) Diagnostic value of18f-fdg pet\/mri for revised 2018 figo staging in patients with cervical cancer. Diagnostics 11:202","journal-title":"Diagnostics"},{"key":"10009_CR65","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.3390\/jcm10174017","volume":"10","author":"M Vermersch","year":"2021","unstructured":"Vermersch M, Mul\u00e9 S, Chalaye J et al (2021) Impact of the18f-fdg-pet\/mri on metastatic staging in patients with hepatocellular carcinoma: Initial results from 104 patients. J Clin Med 10:4017","journal-title":"J Clin Med"},{"key":"10009_CR66","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1148\/radiol.2019190794","volume":"294","author":"JH Yoon","year":"2020","unstructured":"Yoon JH, Lee JM, Chang W et al (2020) Initial M staging of rectal cancer: FDG PET\/MRI with a hepatocyte-specific contrast agent versus contrast-enhanced CT. Radiology 294:310\u2013319","journal-title":"Radiology"},{"key":"10009_CR67","doi-asserted-by":"publisher","unstructured":"Matthew JP, Joanne EM, Patric MB et al (2021) The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int J Surg 88:105906. https:\/\/doi.org\/10.1016\/j.ijsu.2021.105906","DOI":"10.1016\/j.ijsu.2021.105906"},{"key":"10009_CR68","first-page":"622","volume":"45","author":"LM Sawicki","year":"2017","unstructured":"Sawicki LM, Kirchner J, Grueneisen J et al (2017) Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET\/MRI compared to 18F-FDG PET\/CT and CT. PLoS One 45:622\u2013629","journal-title":"PLoS One"},{"key":"10009_CR69","doi-asserted-by":"publisher","first-page":"e0154497","DOI":"10.1371\/journal.pone.0154497","volume":"11","author":"G Shen","year":"2016","unstructured":"Shen G, Hu S, Liu B, Kuang A et al (2016) Diagnostic performance of whole-body PET\/MRI for detecting malignancies in cancer patients: a meta-analysis. PLoS One 11:e0154497","journal-title":"PLoS One"},{"key":"10009_CR70","doi-asserted-by":"publisher","first-page":"247","DOI":"10.21037\/apm.2020.02.30","volume":"9","author":"J Li","year":"2020","unstructured":"Li J, Zhou H, Zhang X, Song F, Pang X, Wei Z (2020) A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies. Ann Palliat Med 9:247\u2013255","journal-title":"Ann Palliat Med"},{"key":"10009_CR71","doi-asserted-by":"publisher","first-page":"W256","DOI":"10.2214\/AJR.10.6331","volume":"197","author":"A Sacks","year":"2011","unstructured":"Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM (2011) Value of PET\/CT in the Management of Liver Metastases, Part 1. AJR Am J Roentgenol 197:W256\u2013W259","journal-title":"AJR Am J Roentgenol"},{"key":"10009_CR72","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.ejrad.2011.01.126","volume":"81","author":"X Qu","year":"2012","unstructured":"Qu X, Huang X, Yan W, Wu L, Dai K (2012) A meta-analysis of 18FDG-PET\u2013CT, 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer. Eur J Radiol 81:1007\u20131015","journal-title":"Eur J Radiol"},{"key":"10009_CR73","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3389\/fonc.2020.01301","volume":"10","author":"Y Ming","year":"2020","unstructured":"Ming Y, Wu N, Qian T et al (2020) Progress and Future Trends in PET\/CT and PET\/MRI Molecular Imaging Approaches for Breast Cancer. Front Oncol 10:1301","journal-title":"Front Oncol"},{"key":"10009_CR74","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40336-019-00319-2","volume":"7","author":"L Evangelista","year":"2019","unstructured":"Evangelista L, Cuppari L, Burei M, Zorz A, Caumo F (2019) Head-to-head comparison between 18F-FDG PET\/CT and PET\/MRI in breast cancer. Clin Transl Imaging 7:99\u2013104","journal-title":"Clin Transl Imaging"},{"key":"10009_CR75","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1007\/s00330-020-06703-1","volume":"30","author":"T Machado Medeiros","year":"2020","unstructured":"Machado Medeiros T, Altmayer S, Watte G et al (2020) 18F-FDG PET\/CT and whole-body MRI diagnostic performance in M staging for non\u2013small cell lung cancer: a systematic review and meta-analysis. Eur Radiol 30:3641\u20133649","journal-title":"Eur Radiol"},{"key":"10009_CR76","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ejrad.2009.12.023","volume":"73","author":"J Czernin","year":"2010","unstructured":"Czernin J, Benz MR, Allen-Auerbach MS (2010) PET\/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination. Eur J Radiol 73:470\u2013480","journal-title":"Eur J Radiol"},{"key":"10009_CR77","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1378\/chest.125.6.2300","volume":"125","author":"FC Detterbeck","year":"2004","unstructured":"Detterbeck FC, Falen S, Rivera MP, Halle JS, Socinski MA (2004) Seeking a home for a PET, part 2: Defining the appropriate place for positron emission tomography imaging in the staging of patients with suspected lung cancer. Chest 125:2300\u20132308","journal-title":"Chest"},{"key":"10009_CR78","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s00259-020-04955-z","volume":"48","author":"SE Dahlsgaard-Wallenius","year":"2021","unstructured":"Dahlsgaard-Wallenius SE, Hildebrandt MG, Johansen A et al (2021) Hybrid PET\/MRI in non-small cell lung cancer (NSCLC) and lung nodules\u2014a literature review. Eur J Nucl Med Mol Imaging 48:584\u2013591","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10009_CR79","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/BF02238010","volume":"43","author":"MH Whiteford","year":"2000","unstructured":"Whiteford MH, Whiteford HM, Yee LF et al (2000) Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 43:759\u2013767","journal-title":"Dis Colon Rectum"},{"key":"10009_CR80","doi-asserted-by":"publisher","first-page":"5719","DOI":"10.3389\/fonc.2021.790462","volume":"11","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Zhou N, Guo X, Li N, Zhu H, Yang Z (2022) Pretherapeutic Assessment of Pancreatic Cancer: Comparison of FDG PET\/CT Plus Delayed PET\/MR and Contrast-Enhanced CT\/MR. Front Oncol 11:5719","journal-title":"Front Oncol"},{"key":"10009_CR81","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12149-021-01580-0","volume":"35","author":"F Crimi","year":"2021","unstructured":"Crimi F, Valeggia S, Baffoni L et al (2021) [18F]FDG PET\/MRI in rectal cancer. Ann Nucl Med 35:281\u2013290","journal-title":"Ann Nucl Med"},{"key":"10009_CR82","doi-asserted-by":"publisher","first-page":"16964","DOI":"10.3748\/wjg.v20.i45.16964","volume":"20","author":"S Kijima","year":"2014","unstructured":"Kijima S, Sasaki T, Nagata K, Utano K, Lefor AT, Sugimoto H (2014) Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET\/CT. World J Gastroenterol 20:16964","journal-title":"World J Gastroenterol"},{"key":"10009_CR83","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1177\/0284185120925481","volume":"62","author":"AC Tsili","year":"2021","unstructured":"Tsili AC, Alexiou G, Naka C, Argyropoulou MI (2021) Imaging of colorectal cancer liver metastases using contrast-enhanced US, multidetector CT, MRI, and FDG PET\/CT: a meta-analysis. Acta Radiol 62:302\u2013312","journal-title":"Acta Radiol"},{"key":"10009_CR84","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/jmri.25852","volume":"47","author":"SH Choi","year":"2018","unstructured":"Choi SH, Kim SY, Park SH (2018) Diagnostic performance of CT, gadoxetate disodium-enhanced MRI, and PET\/CT for the diagnosis of colorectal liver metastasis: systematic review and meta-analysis. J Mag Reson Imaging 47:1237\u20131250","journal-title":"J Mag Reson Imaging"},{"key":"10009_CR85","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1007\/s00259-022-05871-0","volume":"49","author":"SA Mirshahvalad","year":"2022","unstructured":"Mirshahvalad SA, Hinzpeter R, Kohan A et al (2022) Diagnostic performance of [18F]-FDG PET\/MR in evaluating colorectal cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 49:4205\u20134217","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10009_CR86","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1007\/s00259-021-05193-7","volume":"48","author":"FG Gassert","year":"2021","unstructured":"Gassert FG, R\u00fcbenthaler J, Cyran CC et al (2021) 18F FDG PET\/MRI with hepatocyte-specific contrast agent for M staging of rectal cancer: a primary economic evaluation. Eur J Nucl Med Mol Imaging 48:3268\u20133276","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10009_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13244-020-00885-4","volume":"11","author":"F Pesapane","year":"2020","unstructured":"Pesapane F, Downey K, Rotili A, Cassano E, Koh DM (2020) Imaging diagnosis of metastatic breast cancer. Insights Imaging 11:1\u20134","journal-title":"Insights Imaging"},{"key":"10009_CR88","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11547-018-0955-7","volume":"124","author":"G Petralia","year":"2019","unstructured":"Petralia G, Padhani AR, Pricolo P et al (2019) Whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key uses. Radiol Med 124:218\u2013233","journal-title":"Radiol Med"},{"key":"10009_CR89","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/RCT.0000000000000918","volume":"43","author":"M Virarkar","year":"2019","unstructured":"Virarkar M, Viswanathan C, Iyer R et al (2019) The Role of Positron Emission Tomography\/Magnetic Resonance Imaging in Gynecological Malignancies. J Comput Assist Tomogr 43:825\u2013834","journal-title":"J Comput Assist Tomogr"},{"key":"10009_CR90","doi-asserted-by":"publisher","first-page":"360","DOI":"10.2967\/jnumed.109.066217","volume":"51","author":"S Kang","year":"2010","unstructured":"Kang S, Kim SK, Chung DC et al (2010) Diagnostic value of 18F-FDG PET for evaluation of paraaortic nodal metastasis in patients with cervical carcinoma: a metaanalysis. J Nucl Med 51:360\u2013367","journal-title":"J Nucl Med"},{"key":"10009_CR91","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000502821","volume":"85","author":"C Buchbender","year":"2020","unstructured":"Buchbender C, Heusner TA, Lauenstein TC, Bockisch A, Antoch G (2020) Performance of different imaging techniques for detection of para-aortic lymph node metastasis from gynecological malignancies: a systematic review and meta-analysis. Gynecol Obstet Invest 85:53\u201371","journal-title":"Gynecol Obstet Invest"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10009-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-10009-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10009-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T19:04:26Z","timestamp":1705431866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-10009-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["10009"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-10009-3","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,3]]},"assertion":[{"value":"17 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Patrick Veit-Haibach.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare relationships with the following companies: Siemens Healthineers and POINT.PVH received travel support and IIS grants from Siemens Healthineers in the last 3\u00a0years outside of this work. Ur Metser is an advisor for POINT.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors (SAM) has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Not applicable (meta-analytic study).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable (meta-analytic study).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 Meta-analysis\u2022 systematic review","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}